Treatment options for unresectable <fc>HCC</fc> with a focus on <fc>SIRT</fc> with Yttriumâ•'90 res
Y-90-New Treatment Option Available at Bethesda for Patients with Liver Cancer | Bethesda Hospital East
Supplemental Materials for Streamlining TARE or personalizing SIRT? Different philosophies to treat different HCCs with Yttrium-90… - Journal of Hepatology
Radioembolization with yttrium-90 Microspheres for the Management of Uveal Melanoma Liver Metastases: A Review of Clinical Effectiveness and Cost-Effectiveness - NCBI Bookshelf
Diagnostics | Free Full-Text | Hepatobiliary Scintigraphy and Glass 90Y Radioembolization with Personalized Dosimetry: Dynamic Changes in Treated and Nontreated Liver
Leftâ•'liver hypertrophy after therapeutic rightâ•'liver radioembolization is substantial but less than after portal v
Radioembolization for Liver Tumors -
Handbook of Radioembolization: Physics, Biology, Nuclear Medicine, and
Cancers | Free Full-Text | Personalised Dosimetry in Radioembolisation for HCC: Impact on Clinical Outcome and on Trial Design | HTML
Y90 Radioembolization - VIP Physicians Memphis
What's New in Y-90? - Endovascular Today
Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion - Journal of Hepatology
SIRT in HCC
Selective internal radiation therapy (SIRT) before partial hepatectomy or radiofrequency destruction for treatment of hepatocellular carcinoma in cirrhotic patients: a feasibility and safety pilot study - HPB
Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma - Journal of Hepatology
Radioembolization with Yttrium 90
Selective Internal Radiation Therapy | Lovelace Health System in New Mexico
PDF) SIRT and Its Unresolved Problems—Is Imaging the Solution? A Review